❝

“There is a difference between having capabilities somewhere in a large organization and being able to bring them into a startup’s work. Founders should understand who would participate, why the collaboration matters to them, and what a realistic first step looks like.”

Sila’s $1 billion deal signals momentum for silicon anodes

❝

“The battery materials firm Sila Nanotechnologies says it will sell up to $1 billion of its silicon anode materials to the battery maker Panasonic Energy. The deal is a sign that, despite slowing demand for electric cars and the automotive industry’s shift toward low-cost cathode chemistries, high-performance silicon-based anode materials are finding niches in the battery market.

Silicon is almost necessary to achieve the performance required for batteries used by the defense industry, electric aircraft, and data centers, says Charlie Parker, principal consultant and founder of the battery intelligence firm Ratel Consulting. “Silicon is driving these emerging applications.”

Silicon anode materials can store more energy than the same amount of graphite, the material typically used in the anodes of lithium-ion batteries. They also allow batteries to charge faster and pump out energy at a higher rate. The main disadvantage is that silicon costs more than graphite.

Many lithium-ion batteries in cars and consumer electronics already contain a bit of silicon oxide to boost energy density. Sila, and competitors like Group14 Technologies and Nexeon, are making advanced silicon-carbon materials that incorporate higher levels of silicon, which further increases storage capacity.

The research firm Benchmark Mineral Intelligence estimates that, by 2035, engineered anode materials with high silicon content could reach about 3% of the total anode market, measured by gigawatt-hours.”

Technology called “machine perfusion” is creating the chance for more transplants—and daring new science. Image via MIT Technology Review

Researchers in Australia claim they’ve kept a human liver alive, on life support, outside the body for seven weeks, opening up speculative new possibilities in biomedical engineering.

The feat, whose details are pending publication, was carried out in Sydney after a team led by surgeon and inventor Carlo Pulitano connected a donated liver to a system of automated pumps and sensors that fed the organ nutrients, supplied it with blood, and whisked away waste.

In an interview, Pulitano, a transplant surgeon at the Royal Prince Alfred Hospital and a professor at the University of Sydney, likened the life support system to “an artificial body.” Its official name is the Extended Organ Perfusion System. (via MIT Technology Review)